Earlier this year we introduced ARG’s use of Kanban as an organizational model–and tool, as many team members employed a […]
May 15, 2018ARG knows from experience that the willingness to be flexible has fueled our success in rare disease clinical trials, resulting in approvals with over $3B in sales.
May 9, 2018Challenge: In an economic downturn, small biotech companies often depend on clinical milestones in order to maximize shareholder value and […]
May 1, 2018Shay Brill, ARG Vice President of Corporate Development, recently had the privilege and distinction of serving as a judge in […]
April 30, 2018The IDF (Immune Deficiency Foundation) fosters understanding and provides resources concerning PI (Primary Immunodeficiency) disease. ARG joins IDF in recognizing […]
April 28, 2018ARG's history of successfully operationalizing rare disease clinical research has been driven by comprehensive engagement with our sponsors.
April 6, 2018